Heart Health at Your Fingertips: The Power of Remote Monitoring Technologies
In the age of digital health, Remote Monitoring Technologies (RMTs) are becoming increasingly important tools for tracking our health in real-time. These technologies, which can be worn on the body or used at home, allow for continuous and unobtrusive monitoring of the cardiovascular system. This study provides a comprehensive overview of RMTs that measure cardiovascular functions in adults living in the community.
The study is a systematic review of 272 articles, representing 322,886 individuals with an age range from 19.0 to 88.9 years. The researchers found that the most common technology used in RMTs was photoplethysmography, a non-invasive method that detects blood volume changes in the microvascular bed of tissue. The most frequently measured cardiovascular variable was heart rate, and the wrist was the most common location for wearing RMTs.
The study also examined the accuracy and precision of the RMTs. Nine devices were reported in more than three articles, all of which were found to be sufficiently accurate, six were sufficiently precise, and four were commercially available as of December 2022. With over 200 distinct RMTs reported, this review provides a valuable resource for healthcare professionals and researchers interested in monitoring the cardiovascular system.
Article Information
Remote monitoring technologies for measuring cardiovascular functions in community-dwelling adults: a systematic review
Published on Geroscience by Jessica K Lu et al.
Abstract
Remote monitoring technologies (RMTs) allow continuous, unobtrusive, and real-time monitoring of the cardiovascular system. An overview of existing RMTs measuring cardiovascular physiological variables is lacking. This systematic review aimed to describe RMTs measuring cardiovascular functions in community-dwelling adults. An electronic search was conducted via PubMed, EMBASE, and Cochrane Library from January 1, 2020, to April 7, 2022. Articles reporting on non-invasive RMTs used unsupervised in community-dwelling adults were included. Reviews and studies in institutionalized populations were excluded. Two reviewers independently assessed the studies and extracted the technologies used, cardiovascular variables measured, and wearing locations of RMTs. Validation of the RMTs was examined based on the COSMIN tool, and accuracy and precision were presented. This systematic review was registered with PROSPERO (CRD42022320082). A total of 272 articles were included representing 322,886 individuals with a mean or median age from 19.0 to 88.9 years (48.7% female). Of all 335 reported RMTs containing 216 distinct devices, photoplethysmography was used in 50.3% of RMTs. Heart rate was measured in 47.0% of measurements, and the RMT was worn on the wrist in 41.8% of devices. Nine devices were reported in more than three articles, of which all were sufficiently accurate, six were sufficiently precise, and four were commercially available in December 2022. The top four most reported technologies were AliveCor KardiaMobile®, Fitbit Charge 2, and Polar H7 and H10 Heart Rate Sensors. With over 200 distinct RMTs reported, this review provides healthcare professionals and researchers an overview of available RMTs for monitoring the cardiovascular system.
Bring preventive care to your clinic
© Longevity Artificial Intelligence. All rights reserved.